Nivolumab plus chemotherapy in metastatic gastric cancer with low combined positive score.

Ther Adv Gastroenterol · 2025 · PMC12665014 · PMID 41328269

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

16 , 17 Our analysis indicates a possible trend toward improved efficacy with the addition of nivolumab in patients with low CPS, but definitive conclusions cannot be drawn.

also in 888 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.